跳转至内容
Merck
CN
  • Kainate receptor post-translational modifications differentially regulate association with 4.1N to control activity-dependent receptor endocytosis.

Kainate receptor post-translational modifications differentially regulate association with 4.1N to control activity-dependent receptor endocytosis.

The Journal of biological chemistry (2013-02-13)
Bryan A Copits, Geoffrey T Swanson
摘要

Kainate receptors exhibit a highly compartmentalized distribution within the brain; however, the molecular and cellular mechanisms that coordinate their expression at neuronal sites of action are poorly characterized. Here we report that the GluK1 and GluK2 kainate receptor subunits interact with the spectrin-actin binding scaffolding protein 4.1N through a membrane-proximal domain in the C-terminal tail. We found that this interaction is important for the forward trafficking of GluK2a receptors, their distribution in the neuronal plasma membrane, and regulation of receptor endocytosis. The association between GluK2a receptors and 4.1N was regulated by both palmitoylation and protein kinase C (PKC) phosphorylation of the receptor subunit. Palmitoylation of the GluK2a subunit promoted 4.1N association, and palmitoylation-deficient receptors exhibited reduced neuronal surface expression and compromised endocytosis. Conversely, PKC activation decreased 4.1N interaction with GluK2/3-containing kainate receptors in acute brain slices, an effect that was reversed after inhibition of PKC. Our data and previous studies therefore demonstrate that these two post-translational modifications have opposing effects on 4.1N association with GluK2 kainate and GluA1 AMPA receptors. The convergence of the signaling pathways regulating 4.1N protein association could thus result in the selective removal of AMPA receptors from the plasma membrane while simultaneously promoting the insertion and stabilization of kainate receptors, which may be important for tuning neuronal excitability and synaptic plasticity.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
棕榈酸, ≥99%
Sigma-Aldrich
蛋白酶抑制剂混合物粉末, for general use, lyophilized powder
Sigma-Aldrich
棕榈酸, BioXtra, ≥99%
Supelco
棕榈酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
棕榈酸, ≥98%, FCC, FG
Supelco
棕榈酸, analytical standard
Sigma-Aldrich
棕榈酸, ≥98% palmitic acid basis (GC)
棕榈酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
抗GluR1-NT(NT)抗体,克隆RH95, clone RH95, from mouse
Sigma-Aldrich
棕榈酸, natural, 98%, FG
Sigma-Aldrich
抗Myc标签抗体, Upstate®, from rabbit
Supelco
棕榈酸, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
抗-GluR6/7抗体,克隆NL9,兔单克隆, culture supernatant, clone NL904, Upstate®